1. Vermeer SE, Longastreth WT, Koudstaal PJ. Silent infarcts: a systematic review. Lancet Neurology 2007; 6(7): 611–619.
2.
Vermeer SE, Heijer T, Koudstaal PJ, et al. Incidence and risk factors of silent brain infarcts in the population – based Rotterdam Scan Study. Stroke 2003; 34: 392–396.
3.
Lowe G, Rumley A, Whincup PH, et al. Hemostatic and rheological variable and risk of cardiovascular disease. Semin Vasc Med 2002; 2(4): 429–439.
4.
Yoshiyasu T, Kiyoto S, Masaya K, et al. Hemorheologic profile of plasma fibrynogen and blood viscosity from silent to acute and chronic cerebral infarctions. J Neurol Sci 1997; 147(1): 49–54.
5.
Vermeer S, LongstrethW, Koudstaal P. Silent brain infarcts: a systematic review. Lancet Neurology 2007; 6(7): 611-619. To samo co 1
6.
Chien S. What is clinical haemorheology? In: Gotoh F, Lechner H, eds. Clinical haemorheology: a new approach to cerebrovascular disease. Miasto: Royal Society of Medicine Services Limited; 1986: strony rozdziału od–do.
7.
Quemada D. Blood rheology and its implication in flow of blood. In: Rodkiewicz CM, ed. Arteries and arterial blood flow. Vien–New York: Springer Verlag; 1983: 1-127. strony rozdziału od–do.
8.
Lerche D, Bämler H, Kucera W, et al. Flow properties of blood and hemoreological methods of quantification. In: Scütt W, Klinkmann H, Lamprecht I, et al., eds. Physical characterization of biological cells. Basic research and clinic relevance. Berlin: Verlag Gesundheit GmbH; 1991: 189–214.
9.
Chmiel H. Determination of blood rheological parameters and clinical application. Advances in Cardiovascular Physics 1979; 3: 1–44.
10.
Schmid-Schönbein H, Rieger H, Fischer T. Blood fluidity as a consequence of red cell fluidity: flow properties of blood and flow behavior of blood in vascular diseases. Angiology 1980; 31: 301–319.
11.
Dintenfass L. Blood as a near “ideal” emulsion: a retrospective on the concept of the red cell as a fluid drop, its implications for the structure of the red cell membrane. Biorheology 1990; 27: 149–161.
12.
Baskurt OK, Hardeman MR, Rampling MW, et al. Handbook of hemorheology and hemodynamics. Amsterdam, Berlin, Oxford, Tokyo, Washington (DC): IOS Press; 2007.
13.
Woo E, Chan YW, Yu YL, et al. Admission glucose level in relation to mortality and morbidity outcome in 252 stroke patients. Stroke 1988; 19: 185–191.
14.
Kochanek PM, Hallenbeck JM. Polymorphonuclear leucocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367–1379
15.
Chamorro A, Vila N, Ascaso C, et al. Early prediction of stroke severity. Role of erythrocyte sedimentation rate. Stroke 1995; 26: 573–576.
16.
Liu Y, Dong Y-H, Lyu P-Y, et al. Hipertension-induced cerebral small vessel disease leading to cognitive impairment. Chin Med J (Engl) 2018; 131(5): 615–619.
17.
Molisz A, Gutknecht P, Trzeciak B, et al. Ischemic stroke in general practice – risk factors, prognosis – prospective single center study. Fam Med Prim Care Rev 2016; 18(3): 298–301.
18.
Marcinkowska-Gapińska A, Kowal P. Hemorheological studies of chosen clinical cases. J Med Sci 2015; 84(3): 197–200.
19.
Czlonkowska A, Ryglewicz D, Lechowicz W. Basic analytical parameters as the predictive factors for 30 day case fatality rate in stroke. Acta Neurol Scand 1997; 95: 121–124.
20.
Bhatia RS, Garg RK, Gaur S, et al. Predictive value of routine hematological and biochemical parameters on 30-day fatality in acute stroke. Neurol India 2004; 52(2): 220–223.
21.
Wasilewski J, Poloński L. Importance of fibrinogen and the rheological properties of blood in atherosclerosis and coronary artery disease. Chor Serca Naczyń 2010; 7(2): 62–71.
22.
Pulsinelli WA, Levy DE, Sigsbee B, et al. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983; 74: 540–544.
23.
Woo J, Lau E, Kay R, et al. A case control study of some hematological and biochemical variables in acute stroke and their prognostic value. Neuroepidemiology 1990; 9: 315–320.
24.
Beamer N, Coull BM, Sexton G, et al. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke 1993; 24: 1133–1139.
25.
Adams HP, Olinger C, Biller J, et al. Usefulness of admission blood glucose in predicting outcome of acute cerebral infarction. Stroke 1987; 18: 296.
26.
Bokura H, Yamaguchi S, Iijima K, et al. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008; 39: 1607–1609.
